Abstract
Background: There are few studies on the inhibition effects of soy peptides on hepatocarcinoma cells. Further insight into the underlying relationship of soybean peptides and hepatocarcinoma needs to be addressed. Therefore, it is worthwhile investigating the possible mechanisms of soybean peptides, especially the hepatocarcinoma effects.
Objective: In this study, we try to figure out the molecular mechanisms of soy peptides QRPR and HCQRPQ on HepG2 cells.
Methods: First, we use the MTS assay to determine the effect on cell proliferation of soy peptides QRPR and HCQRPQ on HepG2 cells. Subsequently, we examine the apoptosis of HepG2 cells via transmission microscopy and Annexin V-FITC/PI assay induced by soybean peptides. The cell cycle distribution is analyzed using flow cytometry. Finally, we analyze the effects of soy peptides on the TNF-α expression via ELISA assays and the caspase-8 and caspase-3 expression level via western blot and the quantitative real-time PCR.
Results: Soy peptides QRPR used in combination with HCQRPQ can inhibit the growth of HepG2 cells, and the cytotoxicity is low. The transmission microscopy and Annexin V-FITC/PI assay reveal that these two soy peptides induce apoptosis in HepG2 cells. Soy peptide-treated HepG2 cells accumulate in the G1 phase. ELISA shows that soy peptides reduce the secretion of TNF-α. The western blot and the quantitative real-time PCR results show that these soy peptides increased the expression of caspase-8 and caspase-3.
Conclusion: We speculate that soy peptides QRPR used in combination with HCQRPQ can inhibit the growth of HepG2 cells through the TNF-α mediated pathway.
Keywords: Soybean peptide, inhibit cell proliferation, caspase-3, TNF-α, human HepG2 cells, cytotoxicity.
Graphical Abstract
Protein & Peptide Letters
Title:QRPR and HCQRPQ, Two Peptides from Soybean, have an Inhibitory Effect on the Proliferation of HepG2 Cells
Volume: 25 Issue: 10
Author(s): Fengguang Pan*, Lin Wang, Na Guo, Mingdi Zhang and Heqin Xing
Affiliation:
- Laboratory of Nutrition and Functional Food, College of Food Science and Engineering, Jilin University, Changchun 130062,China
Keywords: Soybean peptide, inhibit cell proliferation, caspase-3, TNF-α, human HepG2 cells, cytotoxicity.
Abstract: Background: There are few studies on the inhibition effects of soy peptides on hepatocarcinoma cells. Further insight into the underlying relationship of soybean peptides and hepatocarcinoma needs to be addressed. Therefore, it is worthwhile investigating the possible mechanisms of soybean peptides, especially the hepatocarcinoma effects.
Objective: In this study, we try to figure out the molecular mechanisms of soy peptides QRPR and HCQRPQ on HepG2 cells.
Methods: First, we use the MTS assay to determine the effect on cell proliferation of soy peptides QRPR and HCQRPQ on HepG2 cells. Subsequently, we examine the apoptosis of HepG2 cells via transmission microscopy and Annexin V-FITC/PI assay induced by soybean peptides. The cell cycle distribution is analyzed using flow cytometry. Finally, we analyze the effects of soy peptides on the TNF-α expression via ELISA assays and the caspase-8 and caspase-3 expression level via western blot and the quantitative real-time PCR.
Results: Soy peptides QRPR used in combination with HCQRPQ can inhibit the growth of HepG2 cells, and the cytotoxicity is low. The transmission microscopy and Annexin V-FITC/PI assay reveal that these two soy peptides induce apoptosis in HepG2 cells. Soy peptide-treated HepG2 cells accumulate in the G1 phase. ELISA shows that soy peptides reduce the secretion of TNF-α. The western blot and the quantitative real-time PCR results show that these soy peptides increased the expression of caspase-8 and caspase-3.
Conclusion: We speculate that soy peptides QRPR used in combination with HCQRPQ can inhibit the growth of HepG2 cells through the TNF-α mediated pathway.
Export Options
About this article
Cite this article as:
Pan Fengguang *, Wang Lin , Guo Na , Zhang Mingdi and Xing Heqin , QRPR and HCQRPQ, Two Peptides from Soybean, have an Inhibitory Effect on the Proliferation of HepG2 Cells, Protein & Peptide Letters 2018; 25 (10) . https://dx.doi.org/10.2174/0929866525666181004095501
DOI https://dx.doi.org/10.2174/0929866525666181004095501 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge)
Current Vascular Pharmacology Why and How We Should Treat Elderly Patients with Hypertension?
Current Vascular Pharmacology Association of Low BMI with Aortic Stiffness in Young Healthy Individuals
Current Hypertension Reviews Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design Epidemiology of Hypertension and Diabetes Mellitus in Latin America
Current Hypertension Reviews Developments in Imaging Technologies Related to Hypertensive Cardiovascular Diseases
Current Pharmaceutical Design The Role of the Immune System in the Pathogenesis of Hypertension
Current Hypertension Reviews Circadian Rhythm of Blood Pressure in Diabetes Mellitus: Evidence, Mechanisms and Implications
Current Diabetes Reviews The Concomitance of Hypertension and Diabetes Exacerbating Retinopathy: The Role of Inflammation and Oxidative Stress.
Current Clinical Pharmacology Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Contemporary Management of Hypertension - How to Optimize Therapy
Cardiovascular & Hematological Disorders-Drug Targets Long Chain Omega-3 Polyunsaturated Fatty Acids in Pediatric Metabolic Syndrome
Mini-Reviews in Medicinal Chemistry Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets Effects of Blood Pressure Control in Cardiovascular Prevention
Current Pharmaceutical Design Current Perspectives on Hypertension in Asian Indians
Current Hypertension Reviews Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care
Current Vascular Pharmacology Green Tea from the Far East to the Drug Store: Focus on the Beneficial Cardiovascular Effects
Current Pharmaceutical Design Restoring the Dysfunctional Endothelium
Current Pharmaceutical Design Ambulatory Blood Pressure Monitoring in Prehypertensive Subjects
Cardiovascular & Hematological Disorders-Drug Targets